Demographics (1)
- SEX - Biological sex (phv00483261.v1.p2)
Other (16)
- ANALYTE_TYPE - Analyte Type (phv00377675.v4.p2)
- BloodDrawVisit - Follow-up visit of blood draw for TOPMed specimen (phv00377682.v4.p2)
- BODY_SITE - Body site where sample was collected (phv00377673.v4.p2)
- CONSENT - Consent group as determined by DAC (phv00377666.v3.p2)
- Funding_Source - Project funding source (phv00377678.v4.p2)
- HISTOLOGICAL_TYPE - Type of sample (phv00377674.v4.p2)
- Individual_ID - Subject ID (phv00377665.v3.p2)
- Individual_ID - Subject ID (phv00377669.v4.p2)
- IS_TUMOR - Tumor status (phv00377676.v4.p2)
- SAMPLE_ID - De-identified Sample ID (phv00377672.v4.p2)
- SAMPLE_ID - Sample ID (phv00377670.v4.p2)
- Sampling_Group - Subject sampling groups (phv00377683.v4.p2)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00377677.v4.p2)
- Study_Name - TOPMed-assigned short study name (phv00377681.v4.p2)
- TOPMed_Phase - TOPMed Phase (phv00377679.v4.p2)
- TOPMed_Project - TOPMed Project that funded sequencing (phv00377680.v4.p2)